Drugs / SD-QIV
last change Dec 2018 re-read 3 minutes ago

SD-QIV

Vaccine

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT02936180 Comparator Oct 2016 → Jul 2018 rheumatoid arthritis McGill University Health Centre/Research Institute of the McGill University Health Centre Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SD-QIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT02936180 ↗
Known as FLUZONE Standard Dose Quadrivalent Inactivated Influenza Vaccine “Patients will receive one dose of FLUZONE® Standard Dose Quadrivalent Inactivated Influenza Vaccine (SD-QIV)” NCT02936180 ↗
Modality Vaccine “standard-dose quadrivalent influenza vaccine (SD-QIV)” NCT02936180 ↗